 | • レポートコード：QYR9NV17616 • 出版社/出版日：QYResearch / 2019年11月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、α1-アンチトリプシン(AAT)欠乏症増強療法の世界市場について調査・分析し、α1-アンチトリプシン(AAT)欠乏症増強療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（グラッシア、アララストNP、プロラスチンC、その他）、用途別（病院、専門クリニック）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のα1-アンチトリプシン(AAT)欠乏症増強療法市場動向 ・主要企業別マーケットシェア ・α1-アンチトリプシン(AAT)欠乏症増強療法の種類別市場規模2014-2019 （グラッシア、アララストNP、プロラスチンC、その他） ・α1-アンチトリプシン(AAT)欠乏症増強療法の用途別市場規模2014-2019 （病院、専門クリニック） ・α1-アンチトリプシン(AAT)欠乏症増強療法の北米市場：主要企業・種類別/用途別市場規模 ・α1-アンチトリプシン(AAT)欠乏症増強療法のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・α1-アンチトリプシン(AAT)欠乏症増強療法の中国市場：主要企業・種類別/用途別市場規模 ・α1-アンチトリプシン(AAT)欠乏症増強療法の日本国内市場：主要企業・種類別/用途別市場規模 ・α1-アンチトリプシン(AAT)欠乏症増強療法の東南アジア市場：主要企業・種類別/用途別市場規模 ・α1-アンチトリプシン(AAT)欠乏症増強療法のインド市場：主要企業・種類別/用途別市場規模 ・α1-アンチトリプシン(AAT)欠乏症増強療法の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Grifols、CSL、Baxter、Kamada、Takeda、Abeona） ・α1-アンチトリプシン(AAT)欠乏症増強療法の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Alpha-1 antitrypsin deficiency (AATD) is an inherited condition characterized as a low or unpredictable level of alpha-1 protein, generated by liver. The disease most commonly affects lungs and liver and is often undiagnosed. Augmentation therapy is the most specific therapy for the treatment of AATD, and includes various preparations derived from pooled human plasma.In 2018, the global Alpha-1 Antitrypsin Deficiency Augmentation Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Alpha-1 Antitrypsin Deficiency Augmentation Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Alpha-1 Antitrypsin Deficiency Augmentation Therapy development in North America, Europe and Asia-Pacific.
The key players covered in this study
Grifols
CSL
Baxter
Kamada
Takeda
Abeona
…
Market segment by Type, the product can be split into
Glassia
Aralast NP
Prolastin C
Others
Market segment by Application, split into
Hospitals
Specialty Clinics
Market segment by Regions/Countries, this report covers
North America
Europe
Asia-Pacific
The study objectives of this report are:
To analyze global Alpha-1 Antitrypsin Deficiency Augmentation Therapy status, future forecast, growth opportunity, key market and key players.
To present the Alpha-1 Antitrypsin Deficiency Augmentation Therapy development in North America, Europe and Asia-Pacific.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Alpha-1 Antitrypsin Deficiency Augmentation Therapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Type (2014-2025)
1.4.2 Glassia
1.4.3 Aralast NP
1.4.4 Prolastin C
1.4.5 Others
1.5 Market by Application
1.5.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application (2019-2025)
1.5.2 Hospitals
1.5.3 Specialty Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size
2.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Growth Trends by Regions
2.2.1 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Regions (2019-2025)
2.2.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by by Players
3.1.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue by by Players (2014-2019)
3.1.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by by Players (2014-2019)
3.1.3 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Concentration Ratio (CR5 and HHI)
3.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Key Players Head office and Area Served
3.3 Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product/Solution/Service
3.4 Date of Enter into Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2014-2019)
4.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2014-2019)
5 North America
5.1 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2014-2019)
5.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Key Players in North America
5.3 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type
5.4 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application
6 Europe
6.1 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2014-2019)
6.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Key Players in Europe
6.3 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type
6.4 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application
7 Asia-Pacific
7.1 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2014-2019)
7.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Key Players in Asia-Pacific
7.3 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type
7.4 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application
8 International Players Profiles
8.1 Grifols
8.1.1 Grifols Company Details
8.1.2 Company Description and Business Overview
8.1.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
8.1.4 Grifols Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019))
8.1.5 Grifols Recent Development
8.2 CSL
8.2.1 CSL Company Details
8.2.2 Company Description and Business Overview
8.2.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
8.2.4 CSL Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019)
8.2.5 CSL Recent Development
8.3 Baxter
8.3.1 Baxter Company Details
8.3.2 Company Description and Business Overview
8.3.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
8.3.4 Baxter Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019)
8.3.5 Baxter Recent Development
8.4 Kamada
8.4.1 Kamada Company Details
8.4.2 Company Description and Business Overview
8.4.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
8.4.4 Kamada Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019)
8.4.5 Kamada Recent Development
8.5 Takeda
8.5.1 Takeda Company Details
8.5.2 Company Description and Business Overview
8.5.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
8.5.4 Takeda Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019)
8.5.5 Takeda Recent Development
8.6 Abeona
8.6.1 Abeona Company Details
8.6.2 Company Description and Business Overview
8.6.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
8.6.4 Abeona Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019)
8.6.5 Abeona Recent Development
9 Market Forecast 2019-2025
9.1 Market Size Forecast by Product (2019-2025)
9.2 Market Size Forecast by Application (2019-2025)
9.3 Market Size Forecast by Regions
9.4 North America
9.5 Europe
9.6 Asia-Pacific
10 Analyst’s Viewpoints/Conclusions
11 Appendix
11.1 Research Methodology
11.1.1 Methodology/Research Approach
11.1.1.1 Research Programs/Design
11.1.1.2 Market Size Estimation
11.1.1.3 Market Breakdown and Data Triangulation
11.1.2 Data Source
11.1.2.1 Secondary Sources
11.1.2.2 Primary Sources
11.2 Disclaimer
11.3 Author Details
Table Alpha-1 Antitrypsin Deficiency Augmentation Therapy Key Market Segments
Table Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Covered
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Glassia Figures
Table Key Players of Glassia
Figuer Aralast NP Figures
Table Key Players of Aralast NP
Figuer Prolastin C Figures
Table Key Players of Prolastin C
Figuer Others Figures
Table Key Players of Others
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application in 2018 & 2025
Figure Hospitals Case Studies
Figure Specialty Clinics Case Studies
Figure Alpha-1 Antitrypsin Deficiency Augmentation Therapy Report Years Considered
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Regions 2019-2025 (Million US$)
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Regions 2019-2025 (Million US$)
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Regions 2014-2019
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Regions 2014-2019
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue by by Players (2014-2019) (Million US$)
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by by Players (2014-2019)
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by by Players in 2018
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product/Solution/Service
Table Date of Enter into Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2014-2019) (Million US$)
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Share by Type (2014-2019)
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Type (2014-2019)
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2014-2019) (Million US$)
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Share by Application (2014-2019)
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Application (2014-2019)
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Application in 2018
Figure North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size 2014-2019 (Million US$)
Table North America Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue (2018-2019) (Million US$)
Table North America Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share (2018-2019)
Table North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type 2014-2019 (Million US$)
Table North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type 2014-2019
Table North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application 2014-2019 (Million US$)
Table North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application 2014-2019
Figure Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size 2014-2019 (Million US$)
Table Europe Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue (2018-2019) (Million US$)
Table Europe Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share (2018-2019)
Table Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type 2014-2019 (Million US$)
Table Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type 2014-2019
Table Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application 2014-2019 (Million US$)
Table Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application 2014-2019
Figure Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size 2014-2019 (Million US$)
Table Asia-Pacific Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue (2018-2019) (Million US$)
Table Asia-Pacific Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share (2018-2019)
Table Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type 2014-2019 (Million US$)
Table Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type 2014-2019
Table Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application 2014-2019 (Million US$)
Table Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application 2014-2019
Table Grifols Company Details
Table Grifols Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business 2014-2019 (Million US$)
Figure Grifols Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019)
Table Grifols Recent Development
Table CSL Company Details
Table CSL Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business 2014-2019 (Million US$)
Figure CSL Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019)
Table CSL Recent Development
Table Baxter Company Details
Table Baxter Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business 2014-2019 (Million US$)
Figure Baxter Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019)
Table Baxter Recent Development
Table Kamada Company Details
Table Kamada Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business 2014-2019 (Million US$)
Figure Kamada Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019)
Table Kamada Recent Development
Table Takeda Company Details
Table Takeda Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business 2014-2019 (Million US$)
Figure Takeda Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019)
Table Takeda Recent Development
Table Abeona Company Details
Table Abeona Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business 2014-2019 (Million US$)
Figure Abeona Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019)
Table Abeona Recent Development
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Regions (Million US$) 2019-2025
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Share by Regions (2019-2025)
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Share by Regions in 2025
Figure North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Forecast (2019-2025)(Million USD)
Figure Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Forecast (2019-2025)(Million USD)
Figure Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Forecast (2019-2025)(Million USD)
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Product (2019-2025) (Million US$)
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Product (2019-2025)
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Product in 2025
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2019-2025) (Million US$)
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2019-2025)
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
α1-アンチトリプシン(AAT)欠乏症増強療法のグローバル市場：規模・現状・予測2019-2025 Alpha-1 antitrypsin deficiency (AATD) is an inherited condition characterized as a low or unpredictable level of alpha-1 protein, generated by liver. The disease most commonly affects lungs and liver and is often undiagnosed. Augmentation therapy is the most specific therapy for the treatment of AAT…- 衛星ベースの増強システム（SBAS）の世界市場予測 2023年：メーカー別、地域別、種類・用途別 SBAS systems are geosynchronous satellite systems that provide services for improving the accuracy, integrity and availability of basic SBAS signals. Scope of the Report: This report studies the Satellite Based Augmentation Systems (SBAS) market status and outlook of Global and major regions, from a…
- 時差ぼけ治療アプリのグローバル市場：規模・現状・予測2019-2025 Jet Lag Therapy APPs and gadgets were designed to prevent or cure jetlag.It uses its artificial intelligence engine to calculate a personalized in-flight plan of activities and environmental settings which can help avoid jet lag.For example, at different stages of flight, the Jet Lag Adviser will se…
- 時差ぼけ治療アプリのグローバル市場：規模・現状・予測2019-2025 Jet Lag Therapy APPs and gadgets were designed to prevent or cure jetlag.It uses its artificial intelligence engine to calculate a personalized in-flight plan of activities and environmental settings which can help avoid jet lag.For example, at different stages of flight, the Jet Lag Adviser will se…
- 時差ぼけ治療アプリのグローバル市場：規模・現状・予測2019-2025 Jet Lag Therapy APPs and gadgets were designed to prevent or cure jetlag.It uses its artificial intelligence engine to calculate a personalized in-flight plan of activities and environmental settings which can help avoid jet lag.For example, at different stages of flight, the Jet Lag Adviser will se…